title: Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma.
authors: Onco-Haematology Unit, Nocera-Pagani, SA, Italy. mardarco@alice.it.
authors: Alfonso Maria
authors: AM
authors: D'Arco
authors: Onco-Haematology Unit, Nocera-Pagani, SA, Italy.
authors: Catello
authors: C
authors: Califano
authors: Onco-Haematology Unit, Nocera-Pagani, SA, Italy.
authors: Lucia
authors: L
authors: Barone
authors: Onco-Haematology Unit, Nocera-Pagani, SA, Italy.
authors: Valeria
authors: V
authors: Belsito Petrizzi
authors: Onco-Haematology Unit, Nocera-Pagani, SA, Italy.
authors: Vincenzo
authors: V
authors: Iovino
authors: Onco-Haematology Unit, Nocera-Pagani, SA, Italy.
authors: Maria
authors: M
authors: Langella
authors: Onco-Haematology Unit, Nocera-Pagani, SA, Italy.
authors: Valentina
authors: V
authors: Maglione
authors: Onco-Haematology Unit, Nocera-Pagani, SA, Italy.
authors: Flavia
authors: F
authors: Rivellini
authors: Onco-Haematology Unit, Nocera-Pagani, SA, Italy.
authors: Sonya
authors: S
authors: De Lorenzo
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use; D003606:Dacarbazine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D014747:Vinblastine / Q000627:therapeutic use*; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D001761:Bleomycin; D014750:Vincristine; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin
keywords: ABVD; Hodgkin; dose dense and dose intensity; lymphoma